Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
NCT04473794 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-03-02
Summary
The aims of this study are to determine the natural history of pancreatic cysts and to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant, pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.
Conditions
- Pancreatic Neoplasms
- Pancreas Cancer
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH - lead OTHER
Principal Investigators
-
Elham Afghani, MD MPH · Johns Hopkins University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-20
- Primary Completion
- 2035-11-01
- Completion
- 2036-08-01
Countries
- United States
Study Locations
More Related Trials
-
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
NCT04275557 ·Status: RECRUITING
-
International CAPS Registry: Pancreas Cancer Cases in Surveillance Programs
NCT02703545 ·Status: COMPLETED
-
Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice
NCT02277834 ·Status: COMPLETED
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT03334708 ·Status: RECRUITING
-
Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)
NCT00714701 ·Status: COMPLETED
-
Pancreas Registry and High Risk Registry
NCT02775461 ·Status: RECRUITING
-
Pancreatic Cancer Registry: For Any Person With a Personal or Family History
NCT02886247 ·Status: RECRUITING
-
The Cancer of the Pancreas Screening-5 CAPS5)Study
NCT02000089 ·Status: RECRUITING ·Phase: PHASE3
-
Pilot Study of Pancreatic Cancer Screening
NCT05058846 ·Status: RECRUITING
-
Three New Methods for Diagnosing Pancreas Cancer
NCT00259532 ·Status: UNKNOWN ·Phase: NA
-
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
NCT05287347 ·Status: WITHDRAWN
-
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
NCT06305728 ·Status: RECRUITING
-
Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery
NCT00900016 ·Status: COMPLETED
-
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
NCT05262855 ·Status: COMPLETED ·Phase: PHASE2
-
Early Detection of Pancreatic Cancer
NCT05596435 ·Status: UNKNOWN
-
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
NCT01692873 ·Status: COMPLETED ·Phase: NA
-
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
NCT03260842 ·Status: RECRUITING
-
Early Screening of Pancreatic Lesions : Development of New Imaging Tools
NCT04007640 ·Status: UNKNOWN ·Phase: NA
-
Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical Trial
NCT05253313 ·Status: UNKNOWN ·Phase: NA
-
Imaging Biomarkers of Pancreatic Function and Disease
NCT05659147 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
NCT07117045 ·Status: RECRUITING
-
Early Detection of PDAC in Patients With Chronic Pancreatitis
NCT07104864 ·Status: COMPLETED
-
Optical and Biochemical Biomarkers in Early Pancreatic Cancer
NCT03404661 ·Status: COMPLETED
-
Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer
NCT00897741 ·Status: COMPLETED
-
Early Recurrence After Surgery for Pancreatic Cancer
NCT07241676 ·Status: ENROLLING_BY_INVITATION